403Webshell
Server IP : 134.236.49.22  /  Your IP : 216.73.216.114
Web Server : Apache/2.2.15 (Fedora)
System : Linux km10.dyndns.org 2.6.31.5-127.fc12.i686.PAE #1 SMP Sat Nov 7 21:25:57 EST 2009 i686
User : apache ( 48)
PHP Version : 5.3.3
Disable Function : NONE
MySQL : ON  |  cURL : ON  |  WGET : ON  |  Perl : ON  |  Python : ON  |  Sudo : ON  |  Pkexec : ON
Directory :  /var/www/html/Document/เอกสารเกี่ยวกับระบบยา/

Upload File :
current_dir [ Writeable ] document_root [ Writeable ]

 

Command :

[ Back ]     

Current File : /var/www/html/Document/เอกสารเกี่ยวกับระบบยา/การบริหารยาฉีด.xls
ࡱ>	ebcd	T8\pNurse                                                                                                        Ba==WN8X@"1Tahoma1Tahoma1Tahoma1Tahoma1&Angsana New1&Angsana New1&Angsana New1&Angsana New1&Angsana New1&Angsana New1&Angsana New1&Angsana New1&Angsana New1&Angsana New1&Angsana New1&Angsana New1Tahoma1	Tahoma14Tahoma1
Tahoma1Tahoma1h8Tahoma1	Tahoma14Tahoma1Tahoma1>Tahoma1<Tahoma1Tahoma1Tahoma1?Tahoma1,8Tahoma18Tahoma18Tahoma1&Angsana New1&Angsana New1&Angsana New1& Angsana New1&XAngsana New1&Angsana New1&@Angsana New1&0Angsana New1&Angsana New1&@Angsana New1&Angsana New1$
Cordia New1$@
Cordia New1$
Cordia New1&Angsana New1&Angsana New1&Angsana New1&Angsana New1&xAngsana New1&Angsana New+"?"#,##0;\-"?"#,##05"?"#,##0;[Red]\-"?"#,##07"?"#,##0.00;\-"?"#,##0.00A"?"#,##0.00;[Red]\-"?"#,##0.00e*0_-"?"* #,##0_-;\-"?"* #,##0_-;_-"?"* "-"_-;_-@_-,)'_-* #,##0_-;\-* #,##0_-;_-* "-"_-;_-@_-u,8_-"?"* #,##0.00_-;\-"?"* #,##0.00_-;_-"?"* "-"??_-;_-@_-4+/_-* #,##0.00_-;\-* #,##0.00_-;_-* "-"??_-;_-@_-7?t"?"#,##0_);\(t"?"#,##0\)A@t"?"#,##0_);[Red]\(t"?"#,##0\)CAt"?"#,##0.00_);\(t"?"#,##0.00\)MB$t"?"#,##0.00_);[Red]\(t"?"#,##0.00\)-"C
H";"C
H";"D!HC
H"-"#4";"#4";"@G"+"@4";"@4";"4"],[$ -2]\ #,##0.00_);[Red]\([$ -2]\ #,##0.00\)                                                                          +  )  ,  *     ff  `       	   a>                    P   P !   !  "  #"x@ @	 #"x@@	 # H	 #"x@	 # h@ 	 #x 	 #x@ 	 #x@	 #"x@ 	 #"x@  	 $  %      0 & ( &"8 '  (  ) " (@ " ( @ ( (@ ( ( ( (  ( (@  ( (  ( (   * (@@ +  +" + +8@ @ +8@   +8@ @  +8@@  +8@  +8 @  ( (@ @  ("<@ @  ("8@ @  ," ,  ("8@ @ ("8@  ("8@   ( (@ @ ( (@  ( (@   # h@ @	 # h@ @ 	 #x@ @	 # h@  	 # H
 #"X
 #X
 -"X
 - H
 -X
 . H	 /"x@ 	 /x@ 	 / H	 /x@ @	 /x@  	 /x@ @ 	 #"x 	 #x@  	 #x@ 	 0x@  	 #"x  	 #"x@ 	 #"x@@	 #!x@ 	 #"x@	 #"x 	 #"x@ 	 #"x  	 #"x	 # h	 #x	 #x  	 #x @	 #x@@	 #"x @	 # h @	 0x@ 	 # h 	 #x 	 #!x 	 #!x@  	 #(x@ 	 0x	 0x@	 1 h@  	 1x 	 # h  	 1 h@ @	 1 h@ 	  h@ @	 2x@ 	  h@ 	 # h@	 #"x 	 0x 	  h@  	  h@ 	 #"x 	 #"x  	 # h@@	 # h@	 # h@ 	 #x@ @	 #"x@	 #"x	 #"x 	 #"X	 #"x@ @ 	 #x@ @ 	 #x@ 	 #x@  	 0x@ 	 #X	 #  0x 	 # (@  #"8@ @ #"8  #" #!x@ @	 #x@	 #x 	 #"8@  #"x @	 #"x  	 #"x@@	 #"x@ 	 #"x@	 #"x 	 #"x@	 #"x 	 #"x @	 #"x	 #"x  	 1 h  	 3x@ 	 #"x@ 	 #"x  	 #"x@	 #"x @	 #"x 	 #"x@@	 #"x@	 #"x 	 #"x	 #x@	 1 h @	 #"x@	 #"x 	 #"x@ 	 #"x  	 #"x@@	 #"x @	 #"x 	 #"x	 #"x@@	 #"x @	 #"x@	 #"x 	 /x@@ 	 /x @ 	 /x@@	 /x@	 /x@ 	 /x 	 #"x@ 	 #"x  	 .x	 /x @	 /x  	 #"x	 #"x 	 #"x@	 #"x@@ 	 #"x @ 	 4" $" ) (!8@ (!8 +" (8@ @ (8@   (8@ @ (8@   (8@ @  #"8@  #"8@   #8@ @ #8@  #8@    h@ @ 	 58@  0x@	 2x 	 1 h 	 #x@ @	 5 5" # ||}-}
00_)}-}
00_)}-}
00_)}-}
00_)}-}
00_)}-}
00_)}-}
00_)}-}
00_)}-}
00_)}-}	
00_)}-}

00_)}-}
00_)}-}
00_)}-}

00_)}-}
00_)}-}
00_)}A}
00_)ef[$ -}A}
00_)ef[$ -}A}
00_)ef[$ -}A}
00_)ef[$ -}A}
00_)ef[$ -}A}
00_)ef	[$ -}A}
00_)L[$ -}A}
00_)L[$ -}A}
00_)L[$ -}A}
00_)L[$ -}A}
00_)L[$ -}A}
00_)L	[$ -}A}
00_)23[$ -}A}
00_)23[$ -}A}
00_)23[$ -}A}
00_)23[$ -}A} 
00_)23[$ -}A}!
00_)23	[$ -}-}%
00_)}-}&
00_)}-}'
00_)}-}(
00_)}-}/
00_)}}"
}00_)[$ -##0.??_-	
}-}#
00_)}-}$
00_)}-})
00_)}}*
00_)[$ -???##0.?????_-	???
???}A}+
}00_)[$ -}A},
a00_)[$ -}}-
??v00_)̙[$ -##0.??_-	
}A}.
e00_)[$ -}U}0
00_)[$ -##0.}A}1
00_)[$ -}A}2
00_)[$ -}A}3
00_)[$ -}A}4
00_)[$ -}A}5
00_)[$ -}A}6
00_)[$ -}A}7
00_)	[$ -}}8
???00_)[$ -???##0.?????_-	???
???}}9
00_)[$ -##0.??_-	
}A}:
00_)[$ -}A};
00_)?[$ -}A}<
00_)23[$ -}-}=
00_)}(}>
00_)}<}?
00_)3[$}<}@
00_)3[$}<}A
00_)3[$}<}B
00_)3[$}<}C
00_)3[$}<}D
00_)3[$}<}E
00_)3[$}<}F
00_)3[$}<}G
00_)3[$}<}H
00_)3[$}(}I
00_)}(}J
00_)}-}K
00_)}-}L
00_)}(}M
00_)}(}N
00_)}(}O
00_)}(}P
00_)}(}Q
00_)}(}R
00_)}(}S
00_)}(}T
00_)}(}U
00_)}(}V
00_)}(}W
00_)}(}X
00_)}(}Y
00_)}(}Z
00_)}(}[
00_)}(}\
00_)}(}]
00_)}(}^
00_)}(}_
00_)}(}`
00_)}(}a
00_)}(}b
00_)}(}c
00_)}(}d
00_)}(}e
00_)}(}f
00_)}(}g
00_)}(}h
00_)}(}i
00_)}(}j
00_)}(}k
00_)}(}l
00_)}(}m
00_)}(}n
00_)}<}o
00_)3[$}<}p
00_)3[$}<}q
00_)3[$}<}r
00_)3[$}<}s
00_)3[$}<}t
00_)3[$}<}u
00_)3[$}<}v
00_)3[$}<}w
00_)3[$}<}x
00_)3[$}<}y
00_)3[$}<}z
00_)3[$}<}{
00_)3[$}<}|
00_)3[$}<}}
00_)3[$}<}~
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}(}00_)}<}
00_)3[$}(}00_)}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}(}00_)}(}00_)}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}(}
00_)}<}
00_)3[$}(}
00_)}(}
00_)}(}
00_)}(}
00_)}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}(}
00_)}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}<}
00_)3[$}(}
00_)}(}
00_)}(}
00_)}(}
00_)}(}
00_)}(}
00_)}(}
00_)}(}
00_)}(}
00_)}(}
00_)}(}
00_)}(}
00_)}(}
00_)}(}
00_)}(}
00_)}(}
00_)}(}00_)}(}
00_)}<}	
00_)3[$}<}

00_)3[$}<}
00_)3[$}<}
00_)3[$}(}

00_)}(}
00_)}(}
00_)/20% - *H'5H9@I1]20% - *H'5H9@I1ef%/20% - *H'5H9@I2]"20% - *H'5H9@I2ef%/20% - *H'5H9@I3]&20% - *H'5H9@I3ef%/20% - *H'5H9@I4]*20% - *H'5H9@I4ef%/20% - *H'5H9@I5].20% - *H'5H9@I5ef%/20% - *H'5H9@I6]220% - *H'5H9@I6	ef%/40% - *H'5H9@I1]40% - *H'5H9@I1L%/40% - *H'5H9@I2]#40% - *H'5H9@I2L渷%/40% - *H'5H9@I3]'40% - *H'5H9@I3L%/40% - *H'5H9@I4]+40% - *H'5H9@I4L%/40% - *H'5H9@I5]/40% - *H'5H9@I5L%/40% - *H'5H9@I6]340% - *H'5H9@I6	Lմ%/60% - *H'5H9@I1] 60% - *H'5H9@I123%/60% - *H'5H9@I2]$60% - *H'5H9@I223ږ%/60% - *H'5H9@I3](60% - *H'5H9@I323כ%/60% - *H'5H9@I4],60% - *H'5H9@I423%/ 60% - *H'5H9@I5]060% - *H'5H9@I523%/!60% - *H'5H9@I6]460% - *H'5H9@I6	23%"2#3'{2#3'}%	#I-'2!@7-?I-'2!@7-%$
I-'2!-42"A5
I-'2!-42"%%8@#7H-+!2"8% 2&@@#7H-+!2"8% 2 [0]'<@#7H-+!2"*8%@4(D@#7H-+!2"*8%@4 [0])

7H-@#7H-;

7H-@#7H-I}%*@%%L#'*-@%%L#'*-%?????????	???#+@%%L5H!5%4LS@%%L5H!5%4L}%	,575a%/4%-I-H2yI-H2̙??v%	.2%2A2%2e%/,@-#L@GL0%#'!M%#'!%OO1A"H9A"H%#2*H'5H9@I1Q*H'5H9@I1O%#3*H'5H9@I2Q!*H'5H9@I2PM%#4*H'5H9@I3Q%*H'5H9@I3Y%#5*H'5H9@I4Q)*H'5H9@I4d%#6*H'5H9@I5Q-*H'5H9@I5K%#7*H'5H9@I6Q1*H'5H9@I6	F%8A*%wA*%???%?????????	???9+!2"@+8j
+!2"@+8	:+1'@#7H- 1K+1'@#7H- 1I}%O;+1'@#7H- 2K+1'@#7H- 2I}%?<+1'@#7H- 3K+1'@#7H- 3I}%23=+1'@#7H- 4=+1'@#7H- 4I}%XTableStyleMedium9PivotStyleLight16`&S@7I-+2*2#%0%2"+I2333+!2"@+8"{X
@-*2#-I2-4,Hz'452#@#5"!"2	5BBg 9-'452##4+2#"2A%0'2!1'-"2	5 2"+%1*!#2"2#"2'45#4+2#"2
'2!1' 	+%1*!"225 C 2-8 C*2#%0%2"@7-2 
(IV Fluids for Dilution)
+%1@7-2"2+!2"@+8-IM IV drip in 30-60 minMax conc. 10 mg/ml24 hr48 hr%1.C@G C+I IV drip 2 1-2 
1H'B! Amiodarone  HCl(Cordarone)Cont. IV infusionNSSD5W  AI')( 2
05 '1 1.@GC+IIA* 1.Flush I'" NSS +%12##4+2#"22.+I2!A
H@"G -2@40-DI2.+I2!#4+2#B" IV pushAmoxycillin+Clavulanate 	Cavumox)(Augmentin,5H%31SWI4 hr8 hr1.+I2!#4+2#"2B" IM&2.C
I NSS C2#@7-2@H21I D!A03'C+I*!C Dextrose @7H-2'2!1'H3A%0"2*%2"1'@#G'Amphotericin B (Fungizone)1 wk24 hr C
I*2#%0%2" (1.C
I D5W C2#@7-2"2@H21I +I2!C
I	 NSS, RLSD!H'#C+I"2 < 1 hr%3."2*H'5H@+%7-22#C
I'#4I15	15+%1@7-2Maxconc. 0.1 mg/ml&-2@5" '(#5)0 '#C+I Pre medicationI'" Paracetamol, CPM
Ampicillin1 hr 8 hr $1.+2@7-2C D5W, LRS !5'2! 1'2 hr 5H-8+ 9!4+I- 2.Dextrose 0@#H2#*%2"1'-"2"@7H-2@444#4"2 hydrolysis $3. rapid IV push M2C+I@42#
1DI*4.I2C+IA IV drip '#@%5H"#4@'5H	5+8 48 
1H'B! @7H-I-1 vein irritationAtropine sulfateSC, IM, IV push in 1 min10% Calcium gluconate!2'H2 1-2 secIV push !2'H2 3-5 min  IV drip !2'H2 1 hr4 day'1.Infusion rate D!H@4 0.7-1.8 mEq/min"2. D!HA0M2C+I#4+2#"2B" IM, SC 3. Max undiluted 100 mg/ml 	Cefazolin10 dayNSS, D5W1."2 1 g C
I1'M2%0%2" 2.5 mlCefotaxime (Claforan) 12 hr1.2"2 2 g +I2!#4+2#B" IM2.I-1A*Ceftazidime (Fortum)7 dayCeftriaxone72 hr
NSS, D5W, D5SNSS, D5W, D5S, LRS  @I22+%-@%7-M2$calcium @
H LRS, Ringer s solution !2.D!H'#@7-2"21*2#%0%2"5H!5ChlopheniramineIM, IV slowly !2'H2 1 min#1.'2!@I!I5HC
I	5 IM 1 g/3 ml,(2."23C+I@4 Phlebitis '#@%5H"5H	58 48 -72 
1H'B!Cloxacillin'6HM2C+I!5B-2*@4 phlebitis *96I$*2#%0%2"H-I2D2# !2'H2 NSSA0M2C+IC
I NSS
DexamethasoneIM, SCIV push !2'H2 1-3 minIV drip !2'H2 30 min28 dayDiazepam150 mg/3 mlAdenosine 6 mg/2 mlAmikacin 500mg/2 ml
1.2 g/Vial
50 mg/Vial250 mg/Vial	 1 g/Vial	0.6 mg/ml1 g/Vial10 mg/ml4 mg/mlIV infusionIV push !2'H2 3 min 6 hr1.C@G rate d"1-2 mg/minN2.D!HA0M2 IV infusion @7H-2-2@4
2#0- A%02#91"228"2DI 3.I-1A*'H20C
I2#0- A%0'2!1'D!H5HDiclofenac 
75 mg/3 mlIM only+I2! IV pushDigoxin0.5 mg/2 mlIV push 
I2F!2'H2 5 minDimenhydrinate50 mg/mlIV push over 2 min
Dobutamine250 mg/5 ml Initial 2.5-15 mcg/kg/min titrate Max 40 mcg/kg/min1.+I2!*!C*2#%0%2"B@5"!D! 2#L-@+#7-*2#%0%2"5H@GH2(2.*2#%0%2"-2@%5H"@G*5
! @422#'oxidation D!HM2C+I*9
@*5"'2!A#-"2 Dopamine initial 2-5 mcg/kg/min titrate Max 50 mcg/kg/minNSS, D5W, D5S, LRS
1.Max 6 mg/ml+#7-*2#%0%2"5H@GH2%2.+I2!*!C*2#%0%2"B@5"!D2#L-@"3.I2*5-"2!5'2!@I!C+I4I15Epinephrine (Adrenaline)1 mg/mlIM IV push slowly 5-10 minSC  IV drip rate 1-4 g/min Max conc. 0.1 mg/ml1.@GC 2
0I -1A*)2.D!H'#C
I@!7'-*2#%0%2"@G *5
!9 -H-, I32%-H- +#7-0-#4.# emergency +#7- -8+ 9!4 >30 C 1' 9 @7-
SC, IM, IVFentanyl IV push !2'H2 1-3 minIM, SC 1.Max conc. 50 mg/ml(2.2#C+I rapid injection -2M2C+I @4 	apnea DI
FurosemideIM, IV push !2'H2 1-2 min)1.2#C+I"2@#G'@4 0M2C+I@44) H-+9 2. 42! serum K+)3.I2*2#%0%2"%2"@G*5@+%7-C+I4I15
Gentamicin	80 mg/2ml1.Max conc. 1 mg/ml"2.+%5@%5H"2##4+2#"2B" IV push*@7H-2M2C+I peak serum conc. @4H!6I!5%M2C+I@4H! ototoxicityHyoscine (Buscopan)Imipenem (Tienem) 500 mg/vial 1.D!H'#*!1I3"25H!5 lactate @G*H'#0--2. *!*2#I3 100 ml +2M21I3C+I*! 70 ml &3.% rate +2!5%7HD*I-2@5" #0+'H22#C+I"2Insulin inj  IV infusion 50 unit/min
8 1 
1H'B!
"2*%2"1' 10%KetamineIM, IV push, IV infusion 0.5 ml/kg/min
1'3%0%2"
4#4!2#< 25C+I2!@G	C9I@"G+%1@4	4I15< 30C500 mg+100-200 ml -@GC9I@"G20 ml'#C
I%0%2""2100 ml - NSS10 mlD!HA03C+IA
H@"GI-1A*%2.C9IH'"5H!52#M22-D#H-)3.+2!52##4+2#"2@4 8 hr C+II-1A*)4.@7H-I-1-22# DI +2'*1H %7HD*I	1 g/10 ml1-2 g *!C 100 ml( IV)7.5-10.5 mlin SWI
50-100 ml of 4.Preg Cat C
4 ml : 1 g	3 ml (IM)
10 ml (IV)$1.+I2!#4+2#"25H%0%2"I'" Lidocaine1%Lidocaine(IM)(IV)8-10 ml1.2#*!C D5W 0M2C+I pH -NSS, D5W (50-100 ml)15-30C( 1:1 7- 2#*!"2 250 mg( 250 - 500 ml )C
I diluent  250 mg,conc. 1 mg/ml )250 mg/10 ml+%1@44I15(0.1 mg/2 ml )100 mcg/2 ml
40 mg/2 ml+I2!A
Hopened vial : 24 hr5H -8+ 9!4+I-
( 50-100 ml )4.Preg Cat D20 mg/ml1.Preg Cat CNSS,D5W,D5S10 ML( 3C+I
1DI )2-8Copened vial : 30 day
5H < 25C500 mg/10 mlconc.< 2 mg/ml<  $1.+%1@4C
I @GC9I@"GDI 8 '1Lincomycin Deep IM IV infusion !2'H2 1 hr C2#@7-2"2'2.+I2!C
I LRS +#7- Acetar @G*2#%0%2" 3. '#@G"2B"I -1A* Magnesium sulfate 10% : 10 ml 50% : 2 ml %1.10% MgSO4 D!HI-@7-2"2 H-C+I IV push'2.@G5'-8+ 9!4+I- +I2!A
HC9I@"G 0M2C+I0-MedroxyprogesteroneMeropenem 1 g/vial@G9I@"GD5W3 hr10 hrNSS ( conc.1-20 mg/ml )D5S,D5W ( conc. 1-20 mg/ml )14 hrMethylergometrine 	0.2 mg/mlIV (severe, life-threatening)NSS ( conc.o.2 mg/5ml )Metoclopramide 	10 mg/amp IV infusion !2'H2 15 min IV push !2'H2 1-2 min24-48 hr(@%5H"A*)(BA*)1.@GC 2
0I-1A*Metronidazole 
500 mg/100 mlIV infusion !2'H2 1 hr%2.A
H@"G-23C+I%6 AH0%0%2"DI@-@!7H--8H6I3.D!HA03C+I IV pushMorphine sulfate 4.@GC 2
0I-1A*( 0.1-1 mg/ml)1.+%1*!"2A%I'D!H'#A
H@"GNaloxone inj (Narcan) 0.4mg/ml ( amp )Nicardipine 2 mg/2ml	2 mg/2 ml10 mg/10 ml Slow IV infusion -1#2@#4H!IIV push 1-2 min  2-10 g/kg/minDiluted C NSS, D5WC+IDI conc. 0.1 mg/ml"1.I23@GI-C+I'2!1B%+4%%(-"H2#'@#G' C+I IV push !2'H2 1-2 min)2.'#@%5H"3A+H5HC+I"2@!7H-# 12 hr+I2@G@*I@%7-35HA +#7- 24 hr I2@G@*I@%7-eC+
HNorepinephrine g/kg/min then maintenanceIV infusion initial 8-12 
2-4 g/kg/min
 (Levophed)  4 mg/4 ml (amp)D5W, D5S+I2! *!C NSS@#203C+I@4 oxidationOmeprazole sodium 
40 mg/vial5HA!2-I'"
buffer&citric
acid 3C+I
1'"21'
( 0.4 mg/ml )
( 0.8 mg/ml )5 hrIntrauterus, IV infusion 1 mu/min	SC, IM,  
max 20 mu/min	Oxytocin Control postpartum bleed *!D5W,NSS,RLS!I2 induce labour C
I 10 unit 11,000 ml D5W +#7- RLS (10 mU/ml) 1.C
Iinfusion pump C2##4+2#"22.-8+ 9!425 C !5-2"8 2 5, 2-15C !5-2"83 53.Preg Cat XParacetamolPenicillin G benzathine 1.2 mg/vial3.6 ml-1.- @%5H"#4@'	5"2 8 48 hr @7H-I-1	phlebitisPethidine 50 mg/mlIM, SC, IV push slow 15 hrNSS, D5W, D5S, ARIPotassium chloride injSlow IV infusion 10-20 mEq/hr1.I- dilute H-#4+2#"2(2.2#C+Iperipheral line 31 Max conc. 40 mEq/L$3.2#C+Icentral line 31 Max conc.
 200 mEq/L4.#0'12#@4 extravasation5.Preg Cat CRanitidine HCl 
50 mg/2 ml7.5% Sodium bicarbonate arrestIV push 5 ml/min in cardiac IV drip !2'H2 4-8 hr3% Sodium Chloride500 ml< 35CIV infusion only1.Max conc. 2.5 mg/ml (2. 2#	5@I2+%-@%7-M2C+I@7-21'"2I'" NSS 20 ml rate 4 ml/min 
Streptokinase(Streptase)1.5 mU/vial5 ml
NSS, D5W, LRS+I2! IM( @4 Heamatoma )2.Preg Cat CStreptomycin inj 1 g/vial1 g @4!NSS,SWI
4.2-4.5 ml @7H-DI conc.	200 mg/ml	+#7- @4!
3.2-3.5 ml@7H-DI conc.	250 mg/mlDeep IM onlyIV infusion (30-60 min)
+I2! IV push 14 day1.I-1A**2.*2#%0%2"-2!52#@%5H"*5DI@!7H-4ID'I2 AH"1*2!2#C
I"2DI 3.Preg Cat DTerbutaline 0.5 mg/mlSC, IV push 5-10 min IV infusion 10 mg/min1.I-1A* A%0+I2!A
H@"GSlow IV infusion2-5%(D!HC
I SWI
@7-2<2%@#20%1.@7H-2D!H!5 preservative '#C
I  2"C 24 
1''B!Triamcinolone acetonideIM, Intra-articular, Intralesional, Intrasynovial(H-C+I
@"H2 vialTramadol inj50 mg/ml (amp)Vitamin B complexIM, IV drip2.Preg Cat N/A
Vitamin K1 1 mg/mlIM, SC, IV push slowlyC
I15+%1*!&1.+%5@%5"2##4+2#"2B" IV +2@%5H")D!HDI C+I rate D!H@4 1 mg/min +#7-C+I (IV infusion @7H-2@4 anaphylactoid reaction DI)2.2#	5@I2%I2!@7I--2!5-22# ' '! !3.#9A"2 amp 2 mg/0.2 ml *2!2##4+2#"2B" oral DI'4.D!H'#M2C+I@7-2 AH*2!2#	5 @I2#*H'%H2-
8C+I"22+%- @%7-DI2#@G"2H-*!2 ml:250 mg
3.5 ml:1 g5 ml:500 mg	10 ml:1 g+I2! *!C RLS&sodium bicarbOmeprazole 40 mg+NSS 90 mlOmeprazole 80 mg+NSS 80 ml
 +#7- !50- IV drip -1#2@#G'D!H@4 4 mg/minAdrenaline (1:10) =%0%2" 10 ml (0.1 mg/ml) Adrenaline 1 mg *!C*2#IV infusion !2'H2 	10-20 min @4 salting out effectB#"22% *1+5 !.1013B"'%8H!2@ *1
##!B#"22% *1+5 !.103.Preg Cat B4.Preg Cat C
	+I2! IV push 3.Preg Cat D5.Preg Cat D5.Preg Cat B	1.+I2!*!"2C IV solution2.Preg Cat C3.Preg Cat C1.Preg Cat B2.Preg Cat B1.Preg Cat C1.Preg Cat C/ D (3rd trimester)5.Preg Cat C
1..Preg Cat C(	3.Preg Cat C/D I2C
I@G@'%22/2*9	+I2!C
I  @!7H-*2#%0%2"@%5H"*54.Preg Cat C1.Preg Cat B2.Preg Cat D3.Preg Cat B4.Preg Cat B1.Preg Cat X1.Preg Cat C2.Preg Cat B
5..Preg Cat B(	2.Preg Cat C/D I2C
I@G@'%22/2*93.Preg Cat C
1..Preg Cat B
2..Preg Cat B(	1.Preg Cat C/D I2C
I@G@'%22/2*9
3..Preg Cat B33%8H!2@ *1
##! B#"22%*1+5 !.10 DI13@-*2#*!"2	5 @7H-2"2	50!5*2#I35H*!@I21D!HDI'2!@I!I-"204D+2C
I#4!2#1'3%0%2"D!H9I-, A%0!1!532!@5H"'1'2!1'-"2A%022#5H9I4142II-!9%@5H"'1"2	5DIH-I2"29H!7-2#*!"2	5@%H!5I6DI#'#'!I-!9% Pregnancy categories"2	56H#0-I'"1'3%0%2"A%0#4<  !2#5HC
I%0%2""2 I3@%7-5HC
I@7-2 '452#C+I-#0"0@'%22#	5"2 '2!1'-"2+%1%0%2""2A%0+%1@7-2CI3@%7-,+24%2#02#C  9I13I--- 1"!2  5H5IA%0+'1'H2@-*2#@%H!5I0@G#0B"
LAH9I4142@#5"!*!"2	5  *#I2'2!!1HCC+I19I#4+2#"2L	A%09IH'"DI#1"25H!5'2!%- 1"  +2!5I-**1" *2!2#*-2!DI5H B# 104$	1."2	55H!5%1)0A+I%0%2"I3 !1!58#0*L@7H-C
I#1I@5"'A%0D!H!5 preservative *!-"9H 11I 2"+%12#@#5"! '##5C
IB"@#G'5H*8A%05H@+%7-2."22
46A!I0!5'2!1'!2'H2 24 
1H'B! +%12*!"2C infusion fluid AH@7H-2!5'2! @*5H"-@7I- @
7I-B# 6'##5C
IB"@#G'5H*8  4ID"25H##8C vial +23@GI-C
IH- I-4142! aseptic technique @G-"H25 (D!H'#A@G!C#9@4!) A%0'#@G"2C9I@"G (+2#4)19I%4A03C+I@GDI)w  A%0#5C
IH-C+I+! 2"C#0"0@'%25H"21'D!H@424 
1H'B! 6A!I'H2"21I0!5'2!1'2@!5!2'H2 24 
1H'B!G2!US FDA Pregnancy categoriesCategory A  :  !52#(6)2A controlled study C+
4!5## L'H2D!H!5'2!@*5"C2#-C+I@4'2!44H-2#C## L@!7H-C
ICD#!2*A#A%0D!H!5+%12 Category B : 1.2#(6)2C*1'%-'H2D!H!5'2!@*5H"C2#3C+I@4'2!44-1'-H-C## L AHD!H!5#2"22#(6)2A controlled study C+
4!5## L 2.2#(6)2C*1'%-'H2!5'2!@*5H"C2#3C+I@4'2!44-1'-H-C## L AHD!H%1%H2'22#(6)2A controlled study C+
4!5## LCategory C :r 1.2#(6)2C*1'%-'H2!5'2!44-1'-H-C## L AHD!H!5#2"22#(6)2A controlled study C+
4!5## LI 2.D!H!5#2"22#(6)2C!8)"LA%0*1'L6%-"2H-1'-H-+#7-2#C## Li  2'4
22#5HA*C+I@+G'H2!5'2!@*5H"H-2#@4'2!44-2#C## L@!7H-C
I
H'D#!2*5H 2 A%0 3l  C2##1)2B#5H#8A#6HD!H*2!2#C
I"25H%- 1"'H2DI +#7-C
I"25H%- 1"'H2A%I'D!HDI%2!5HI-2#Category D :  !5+%12'H2@4-1#2"H-2#C## L AH@!7H-@5"#0B"
L1%@*5"A%I'G"1"-!#15H0C
IC2* '05H3@GDIAH 2#C
I"2@7H-#1)2
5'4 +#7- 2#C
I"2Category X : 2#(6)2C*1'%-A%0+
41I## L'H2@4-1#2"H-2#C## L A%0@!7H-@5"#0B"
L1%@*5"5H@46IA%I''H2 %@*5"!2'H2 11I"25H-"9HC( %8H!5I@G"25H+I2!C
IC+
41I## L
@-*2#-I2-4J1. Trissel LA. Handbook on injectable drugs. 13th ed. Maryland: AHSP; 2005*2. 1

5'2!1'-"2	5 B#"22% 
%8#5(3. 1

5'2!1'-"2	5 B#"22% *9%4. @-*2#31"2,2#42%@ *1
##! %8H!2@ *1
##! B#.104:'452#@#5"!"2	55H!53*1H4@()CB#"22% *1+5 !.10%315H
7H-"23*1HC
I"2'2!@I!I
#4!2#5HC
I#4!2#*2#%0%2"
#4!2##'!
'452#@#5"!Adrenaline 1 mg/ml (amp)	0.1 mg/ml2 ml (2 mg)18 mlDopamine 250 mg/10 ml (amp)2 mg/ml3 mg/ml5 mg/ml6 mg/ml
4 ml (100 mg)
8 ml (100 mg)
8 ml (200 mg)12 ml (300 mg)16 ml (400 mg)20 ml (500 mg)24 ml (600 mg)C
I NSS/D5W 2 100 ml #C
I NSS/D5W 2 100 ml 9-- 4 ml100 ml#C
I NSS/D5W 2 100 ml 9-- 8 ml$C
I NSS/D5W 2 100 ml 9-- 12 ml$C
I NSS/D5W 2 100 ml 9-- 16 ml$C
I NSS/D5W 2 100 ml 9-- 20 ml$C
I NSS/D5W 2 100 ml 9-- 24 mlDobutamin 250 mg/20 ml (amp)16 ml (200 mg)Nicardipine 2 mg/2 ml (amp)C0nc.!2#2 0.1 mg/ml6 amp (12 mg )112 mlNorepinephrine 4 mg/4 ml (amp)
1 mg/10 ml
1 mg/25 ml10 ml (10 mg )4 ml (4 mg ) C
I D5W 2 100 ml 9-- 10 mlC
I D5W 2 100 ml 9-- 4 ml250 mg/20 mlClindamycin 600 mg/4 ml#1.+I2!A
H@"G @7H-2-2@40-A%0 cardiopulmonary arret)	2.D!HC+I IV push -23C+I@4 Hypotension
NSS, D5W, LRS 300 mg + 50 ml (10 min)600 mg + 50 ml (20 min)900 mg + 100 ml (30 min)1,200 mg + 100 ml (40 min)Ephedrine  30 mg/ml10 U/mlNitroglycerine
5 mg/10 mlNSS, D5W (conc.<0.4 mg/ml)NTG (1:5) = NTG 1 mg + 5mlNTG (1:10) = NTG 1 mg + 10mlIV infusion C-1#2 5 g/mintitrae 5 g/min q 3-5 min'1.conc. 50-100  g/ml D!H@4 100  g/m 300 mg/2 ml
 20 mEq/10 mlPenicillin G (sod)1,000,000 u/vial5,000,000 u/vial3 ML :8 ML :	0.5 mU/ml1 mU/mlIM,IV infusion@%5H"5H	58 48 hrs @7H-I-1 phlebitis,1.2#C+I IV push 0@4H!'2!@*5H"H-2#@4nerotoxic 6D!HA03	Phenytoin+%5@%5H" IM ( '!2 )IV bolus 	5 50 mg/min IV infusion diluted C 50-100 mlNSS,RLS (conc. 1-10 mg/ml)A
H@"G-20- AH*2!2#%0%2"0-5H-8+ 9!4+I-A%03!2C
IC+!HDIB"D!H!5%H-1 hr@#5"!15H-C
IC+IA
H@"G'1.flush I'" NSS H-A%0+%12##4+2#"22.C
I"215+%1@7-23.'2!1'+%1@4' 24 hr(4.D!H@G*2#%0%2"5H@7-2A%I'C9I@"G
5..Preg Cat D	10 mg/ml @I21)A#F'H2"20Hydralazine 20 mg1 mlA03@	20 NSS @H<  21IIM,IV push slowly D!H@40.2 mg/kg/ml!1.+I2!*!C*2#%0%2"5H!5 dextrose* @7H-2@%5H"@G hydrazones 6H3C+I*@4 toxicity @
H '+1' %7HD*I -2@5"Hydrocortisone 100 mg/vialIV infusion 20-30 minNSS, D5W, D5S,LRS!1."25H%0%2"A%I'@GB"I-1A*&2. +I2!*! Glucose @#200!52#*%2"1'3.Preg Cat C20- 25CSWI,2 ml%3.ampule @G5' -8+ 9!4 d"25 C +#7-(d" 30 C AH!5@#7H-#1-22( 1' 2 5
@H21I (#0Neostigmine 	2.5 mg/mlIM,IV,SCIV push over 20-30 secAH0!5I-HC
I4@() @
H malignant hyperthermia
NSS, D5W Max conc. 10 mg/ml
1.+I2!A
HAG)2.D!H'#@7-2 < 2 mg/ml @7H-2@G  emulsion 6D!H1' 3.2#+""2B"D!HDIM2C+I@7-2I-D!H@4 12 hrPropofolThiopental (sod)1 g/ampSuxamethonium*(Succinylcholine)	25 ML(2%)
10 ML (5%)IM,IV,IV infusionNSS, D5W,D5S24 HRmax rate < 30 mg/min	

 Conc. < 2 mg/mlIV drip C
H' 30 minIV drip  IV push !2'H2 3-5 min  D5W IV push 3-5 minIv drip 60 minIV infusion 10- 20 minC
I diluent  250 ml,60 min( RI )( NPH, Mixtard )IV drip !2'H2 3 hrsIV push slowly 5 min 10-20 unit 1 1,000 ml - IV infusion 30 min IV infusion !2'H2 30 min	 IV push IV push 10  min #5 IV infusion Conc.  2 mg/mlIV push  10 min IV drip  60 min IV infusion 60 minIV infusion 60 min#	1.IV push '#@7-2"22 > 4 @H2(	 IV infusion '#@7-2"22 > 250 @H2SC IV drip in 60 min  C@G dilute I'" SWI 15 mg/ml+#4+2#"2-7H+%1"2 gentamicin -"H2I-"1 hr(3.I2I-C+I#H'!1"24
5'0
4-7H'#
Hemodialysi ) Hypotonic@4)1.+I2!C
IC
H' 3 @7-A#-2#1I## LAcyclovir sodium 500 mg/ vial-20-12 
!.
+%5@%5H"IV infusion ( e" 1 
!. )D5W, NSS,D5N,LRS Max conc 5 mg/ml@7H-I-1 Phlebitis%3.+I2! IV Push 3C+I@4 crystalluria6.pH +%1*!"2 11 1.+I2!#4+2#"2B" IM A%0 IV push*2."2 1 amp/*2#%0%2" 125 ml  I231I3C+I@7-2 1 amp/*2#%0%2" 75 ml)3.+2@7-2 < 50 ml -2@42#0-DIC+II-1A*'H20C
INSS,.D5W  125 ml                     75 ml                    100 ml                     50 ml2 hrIV drip in 60-90 minBactrim inj(Sulfamethoxazole/
Trimethoprim)IM,SC
1.+I2!A
H@"GLevofloxacin 250 mgFluphenazine decanoate25 mg/ml25-30C7.Preg Cat B(1.+%1*!"2A%I'D!H'#A
H@"G3C+I0- 25-30C400+80 mg/ml&4.+%1@7-2A%I''#C
I 2"C 6 
1H'B!!I2C+I D5W !5'2!1' 24 
1H'B!5.+I2!@GC9I@"G6.Preg Cat C,D at near termIV infusion > 60-90 25IV infusion @H21I#4+2# IV infusion > 60 2 IV infusion > 60 2  2"2 250-500 mg C+I   2"2 750 mg C+I#4+2#500mg/100ml+%1@4'NA	300 mg/ml+1.C+I IV drip @H21I 2##4+2#B" IV push-23C+I@4 Hypotension DI&2.+%123'--2%H- '2!C
I 2"C3 '1&3.+%12@4' '#C
I 2"C 3 
1H'B!*2.conce"10 mg/ml 0@4H! risk Phlebitis A%0-extravasation I231*2#I3C+I conce"10 mg/ml*4.'##4+2#"2 e"@7H-+%5@%5H"-1#2"H-D/5.@7H-%'2!@*5H"H- Nephrotoxicity '#C+I*2#&I3-"H2@5"- H-A%0#0+'H22#C+I"2%2.*2#%0%2"##8C 2
0%2*4 PVC '#+ C
I 2"C 2 
1H'B!,  Polyolefin 1'24 hr$3.@"!5#2"2 *!C NSS A%I' 0-C 24 hr+4.Amiodarone !5'2!@G1I'H3 %0%2"I3I-" @!7H-*! NSS 0%0%2"DII-")2.D!HA03C+I*!1"2%8H! Aminoglycoside IV push 1-2g/10 ml	2.5 ml IM'2!@I!I-"2 +I2!*!C*2#%0%2"5H!5 dextrose IV infusion D!H@4 60 min @'I
4.Preg Cat  C
Azithromycin conc.1mg/ml:IV drip in 3 hrconc.2mg/ml:IV drip in 1 hr4.8 ml
D5W, NSS, LRSC+IDI#4!2#   500 ml  (conc 1mg/ml)  250 ml (conc  2mg/ml)1.+I2!#4+2#"2B" IM/ IV Push,2.2##4+2#"2A IV infusion C+I2'H2 1 
!.3.#4!2#*2#%0%2"5HC
I@7-2-"H2I-" 250 ml    @7H-I-12#@4 Phlebitis4.Preg Cat B-1."2 1 g C+IC
I*2#%0%2" > 100 ml C2#@7-2	20-30 minA'22##4+2#"2	5  2561Albumin Human 20%in 50 ml inj(I-1A*)+""2@I2+%-@%7-32 30-60 25+%1@4C
IC+I+!C 4 
!. @+%7-C+I4ID5W,NSS4 
!.-1.+I2!C
I SWI C2#@7-2 @7H-2@4H!'2!*@*5H"C2#@4 fatal hemolysis A%0 acute 
renal failureCiprofloxacin 2 mg/ml
in 100 ml injA* +I2!A
HAG@#20-2
@40-)-"H2I-" 60 25 (@7H-%'2!@*5H"22##02"@7-+%-@%7-3)+%1@4C+IC
IC+I+!@+%7-C+I4I14 '1( conc 0.5-2 mg/ml)'1.*2!2#@4 Anaphylaxis DIC dose A#%2.C* 2'05HBA*#0*44 2-"29#01D'I@G@'%2 3 '1C-trimoxazole injIV infusion 60-90 25(D!H'#2@4 90 256 
!.(80mg/125ml)(80mg/100ml)2 
!.(80mg/75ml) 1.Preg Cat C @!7H-C%I%- Cat D,2.C#2"5H31I3C+I*!C -1#*H' 1:15 DIEnoxaparin Sodium
40 mg/0.4 ml,60 mg/0.6 ml(+I2!A
HAG)1.SC2.IV bolus *3+#1#1)2STEMI @H21I))1.D!H'#D%H--22(H-	5@7H-+%5@%5H"2#*9
@*5""2)2.+2I-	5 IV '# flush I'" NSS+#7-D5WH-A%0+%1C+I"2<Ertapenem 1 g inj1-2%Lidocainwith out
epinephine1.IV Infusion : %0%0""2 1 g2.IM : %0%2""2 1 g I'" 3.2 ml- 1% lidocain @7H-%'CSWI/NSS 10 ml > 30 2524 
!.conc.d" 20 mg/mL+I2!*!C*2#%0%2"5H!5Dextrose	(C
I 2"C
4 
!. +%1--29I@"G)*1.+I2!*!#H'!1"2-7HA%0+I2!C
I*2#@7-25H@G Dextrose 00-2.Preg Cat BHeparin sodium5,000 U/ml, 5 ml inj	2.IV push3.IV infusion in 4-24 
!.(-2@4 Hematoma formation)+I2!	5 IM 4 '1(20u/ml) +#7-2!A"L*1H+I2!C
II2@%5H"*5+#7-0-Methylprednisolone(sod.succinate)20-25CD5S,2.IV push over 3-15 2548 
!.D5N/2NSS,D5W,D5S,D5N/22.Conc. *9 +I2!C+I IV push3.D!HA03C+IA
H@"G 1.IV Infusion : over 30-60 25 Tranexamic acid250 mg/5 ml inj1.Direct IV : slowly>5 25D!H@4 1 ml/25 2#C+I@#G'-2@4 Hypotension, max rate 100 mg/min2.Intermittent IV :15-30 25NSS,D5WVancomycin(HCI) IV drip over 60 25@7H-I-12#@4red man syndrome7 '1-"H2I-" 100 ml#('2!@I!I*9*8 D!H@4 5 mg/ml)2.2"2 500 mg *!C100 ml3.2"2 1 g *!C 250 ml4.Final conc. 5 mg/ml5.+I2!C+I IM @#20-2@4tissue necrosisVit.b1 inj 100mg/1ml
I-1A*1.D!HA0M2C+I Direct IV @#20-2@4 anaphylaxis DI2.Preg Cat A
100-500 ml0~|@X4ȁׂ4~Z	

fB݌;	ʏ*fs5gCxT2כU1ʝ]x̠]8n-I`	)	Q_:
Эm,ϱW>&e$IMCR_xB9dx[UQ))^[F@1ZHuu37
K
_o
J1Nu|)on&/*}6ccB
	T8L+:nHNW
et
|"
dMbP?_*+%&M&d2?'(M&d2?)M&d2?MESamsung ML-1860 Seriesg߁	4dXA4PRIV	x-ArialUntitled0:0:0:0:0dX222222222pichatA4dddddd			44@@44#"	dX
BP(?
BP(?&\(U}@v}@w}x}x}@
x} x}v}v}x}			v}

@	v}w}	w
y||||||||	|
|||
wAwAwA
wA
wA
wA
A
A
wA
wA
wA
wA
wA
wA
wA
A
wA
wA
wA

}#
}
}

}

}
	

}
{"{
{
}
}{

{
	


{
~~
~~~~


~	
	

~~
z?

q
$





	


z
ADF
E

D	


zDF{

D	


zDF{

zDF{

	zDF{

	
zDF{


zDF{

zDF~

~

?@

p

q



q

q




q

	?


?


G
E
DE
EGEGG


G
EDEEEGG

3HHH

~
G@
4
E

q
E
:
E<
	=


o>G
5
E
DE
E8
;E

C?
G
E6
DE
E9E

C@
G
E7DEEE

~
?@
oq
q
q
q
q



q
	


oGCEEF
E

E[
	

CHr



	

r~
?@
o
q
q
q
q

q
	?


oG
EEE
E

E
	G

CG
CoEEEE
E
	G

CGCEEEE
E
	G

CGCEEEE
E
	G

CGCEEEEEG

CGCEEEEEG

CGCEEEEEG

CDl.|Z......ZD.pZDZZxbDD.8 wA!wA"wA#wA$wA%wA&wA'wA(wA)wA*wA+wA,wA-wA.wA/wA0wA1wA2wA3wA4wA5wA6wA7wA8wA9wA:wA;wA<wA=wA>wA?wA HrH

 r~
!@
!C
!D
!E$
!E
!E
!G
!G
!E
!	G%
!
&
!C'"
"C!
"D"EEC
"G4
"G"EG

"C(#
#C #DEEE
#G
#G#EG

#C)$
$Cr$DEEE
$G
$G$EG

$C*%rHHH

%r~
&?@
&C+
&
&q$
&
&q
&.
&?-
&
&	/&

&0'G
'C,
'D'EF
'
'G
'F6
'	4'

'1(G
(Cs(EEFE
(
(G(F
(	5(

()GCEEFEGFB

)2*GCEEFEGFB

*+GCEEFEGFB

+,GCEEFEGFB

,7-GCEEFEGFB

-8.GCEEFGF

.~
/? @
/o9
/q
/q$
/q
/q
/?:
/?%
/q
/	?;
/

/o<0G
0Ct0EEEEGGEG

0C=1G
1Cu1EEEEGGEG

1C>2GCEEEEGGEG

2C?3GCEEEEGGEG

3C@4GCEEEEGGEG

4CA5GCEEEEGGEG

5CB6GCEEEEGGEG

6~
7?"@
7oC
7q
7q
7q
7qD
77
7
7	?
7

78H
8rv8
8E8
8	H8

8~
9G$@
9C$
9q
9E$
9E'
9%
9?
9W
9(
9	G
9
W
9,:GCEEE
:&
:G
:)
:	G

:-;GCEEEFG
;*
;	G

;.<GCEEEFG
<+
<	G

</=GCEEEFGG

=0~
>?&@
>o>q
>q
>q
>
>?
>?
>
>	?|
>

>?G
?C?EEEFG
?
?	G%?

?DP
l.pdd.v......BB.....lZDD.@wAAwABwACwADwAEwAFwAGwAHwAIwAJwAKwALwAMwANwAOwAPwAQwARwASwATwAUwAVwAWwAXwAYwAZwA[wA\wA]wA^wA_wA@G
@C@EEEFG
@
@	G@

@AG
ACAEEEFG
A
A	GxA

ABGCEEEFGG

BCGCEEEFGG

CDGCEEEFGG

DEGCEEEFGG

EFHrHH

F~
GG(@
GCF
GE
GE
GE
GF
GG
GD
G	G
G
BJ
GCKHG
HC
HE
HEE
HFI
H
HD
H	GB

HCL
IGC
IEIEEFBDGB

ICMJHrH

J~
K?*@
KoN
Kq
Kq$
Kq
KE
KG
KGO
Kq
K	?
K
@J
KoQLG
LCw
LEE
LELE
LG
LG
LEP
L	GB

LCMGCEE
MEMEGGEGB

Mr~
N?,@
NoR
Nq
Nq$
Nq
Nq
N?S
N?
NqP
N	?S
N
?
NoTOG
OCwOEEEE
OG
OGOE
O	G
O
G
OCUPHr
PH
PHP
P	H
P
H
Pr~
Q?.@
QV
Qq
Q$
Qq
Qq
Q
QW
QZ
Q	?
Q
W
QobRG
RCw
RD
RERDDG

RCSGDEDDG

SCcTGDEDDG

TCdUHH

Ur~
VG0@
VCX
VF
VE
VD
VE
VG
VGY
VE
V	G
V
GY
VCWG
WCwWF
WE
WDWEGG
WEZ
W	G

WC\XGCFEDEGGEG

X^YGCF
YE$
YDYEGGEG

YC]ZHr
Z
ZZHHH

ZC~
[?1@
[o_
[
[q
[q
[q`
[[
[q
[	?
[

[o\H
\rx\
\a\Hr~
]?2@
]oA
]
]q
]
]q
]J]
]P
]	L]

]oN^G
^CB
^F6
^EF
^EG
^K
^F
^	M^

^CO
_GC
_FC
_EF
__F

_CPDlbb.....zD.DzfX...x.PPL`wAawAbwAcwAdwAewAfwAgwAhwAiwAjwAkwAlwAmwAnwAowApwAqwArwAswAtwAuwAvwAwwAxAywAzwA{wA|wA}wA~wAwA
`GC
`FD
`EF
`EH`F

`C
aGC
aFE
aEF
aEIaFC
bHr
bFbr~
c?3@
coN
cq
cq
cq
cq
cc
cqS
c	?
c

coPdG
dCO
dEdEEE
d
d	G

dCR
eGC
eEeEEE
eET
e	G

eCQfGCFEEE
fEU
f	G

fCgGCFEEE
gEVg	GChHr
hWh	Hr~
i?4@
ioe
i
iq$
iq
iql
i?
i?
iqP
i	?
i

iojG
jCwjEEEEGGEG

jCgkGCEEEEGGEG

kCflGCEEEEGGEG

lChmHrEHHH

mr~
nG5@
nCQ
n
nq
n
nqR
nn
nE
n	?T
n

noYoGCFEF
oESoE
o	GUo

oCZpGCFEF
ppE
p	G=p

pCqGCFEFEE
q	GVq

qCrGCFEFEE
r	GW
r
CsGCFEFE
s	HX
s
r~
t?6@
toi
t
tq
t
tEj
tt
tq
t	G
t
m
tCuG
uCyuEEF
uEkuEGCvHr
vlvHr~
w?7@
won
w
wq
wq
w{
ww
wP
w	?
w
|
wo}xG
xCxxEEEFDG

x~yGCEEEFDG

yCzGCEEEFDG

zC{HrH

{r~
|?8@
|o
|
|q
|q
|q
||
|q
|	?
|

|o}H
}r}
}}Hr~
~G9@
~C
~E
~E
~E
~F
~~
~DP
~	G
~
B
~CG
CEEE
FDGB

CDt
lZN8dZD88B...XXB88L8B...LwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAHrH

r~
?:@
o

q
q
q`

qP
	?O

?
CH
r
HHC~
?;@
o

q
q
z


	?


oG
CMEEE
F

D
	G

CGCEEE
F

D
	G

CGCEEE


D
	G

CHrH

r~
?<@
o
q
q
q
qz

q
	?

?
oG
CEEE
E

E
	GG

GCEEE
E

E
	GG

CGCEEE


E
	GG

Hr

	HH

r~
G=@
C[
q
q
q
`

D<
	G


CcG
C\
E^
EE
aDG

CdG
C]
E_
EE
	bDG

CeGCEEEDG

Cf~
?>@
o
q
q
q
q

q
	?

?
oG
CEEE
E

E
	GG

CGCEEE
EEGG

CGCEEE
E

E
	GG

CGCEEEE
G
	GG

CGCEEEE
E
	GG

CGCEEEEEGG

CHrHH

r~
?@
pX






	


pG
Cg
D
E
F
l
?T
p
D
	GT

p
Cx
GC
E^
E$F
o
G
Dq	G

t
Cy
GC
E_
EhF
m
G

r	G

u
CzGCE
EiF
n
G

s	G

vCGCE
EjFFGDG	

wCGCE
EkFFGDGCD0l.LnZZ.nZZDdd.nDZDD..~LwAwAwAwAwAwAwAwAwAwAwAAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwA~
?@@
o
q
q


P
	?

oG
CEEF
FDG

CG
CEEF
FDG

CHrH

r~
G@@
C
q
D
D
q
?
?
D
	G

G
CG
CDDHHDG

~
?A@
o


F

P
	?

oG
C
D
DE
FDG

CG
C
D
DE
FDG

CGCDDEFDG

~
?A@
o
q
q
q
q

qZ
	?

?J
G
C
E
EE


E
	GG


GC
E
EE



	GG

GCEEE
E
	GG

GCEEEEEGG

GCEEEEEGG

HrGG

~
GB@
{
E
D
D
F`
?

<
	p

G
|DDD
F}
G
	GDDD
F~GGDDD
FGGDDD
FH~
?B@


$




	GS



G
E
DD
FG

C
G
E
DD
FG

CH
zH

~
?C@
o
q
q
q
q
?Y
?
q
	?%
?
oG
CE
EE
EGGEGG

CHr
HHHH

~
GC@

E
D
D
E
G
G
E
	G

G
H
HHHHr~
GD@
C
q
E
E
E
G%
G
EZ
	G%

B
oDlXX.Bdd.pD...b888ZZDjD6wAAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAG
CE
EE
GGEGB

CGCEEE
GGEGB

GCEEE
EGGEGB

CGCEEEEGGEGB

CHrHHH

~
?D@
o
	
q
q
qD


q
	

H
r



	

r~
?E@
o
	
q
q
q


q
	

H
r


	

r~
?E@
o
q
q
q
q

qP
	?

?
oH
r




	HH

~
GF@
C
q
E
E
?
?
?
qZ
	G 

G

CG
CEEE
GE
	G
G
C
GCEEE
GE
	G	
G
CGCEEE
GEGG

CGCEEE
GEGG

CGCEEE
CGEGG

#~
?F@
o
q
q
q
q

?
qZ
	?

?
o1G
CEEE
EGEGG

CGCEEE
GEGG

CGCEEEEGEGG

HrHHH

~
?G@
o
q
q
q
q


Z
	?
?
oG
C
E
EE
EDGG

CG
C
E
EE
EBDGG

CGCEEEEBDGG

CHrHH

~
?G@
C
E
E
E
E
G
G
E
	G

G
H
roEGGHHr~
?H@
o
q
q$

E
?&
?
q
	?

?
GCE
E
DE
G&
G
E"
	G&

GCHr


H 
H!
#
	H 

H$rD
ljDD..nbnlXDDDXD..dd..6|wAwAAAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwA~
?H@
o%
q
q
q
q`

q(
	?

?
H
r&
'HHr~
GI@
C
q


E

?

E
	?


G
CE
E
G

EG	


CG
CE
EEGEG

C~
?I@
o)
q
q
q
q
?
?
qZ
	?-


o0G
C*EEE
E,GGE
	G.

GCEEE
E+GGE
	G

CHrHH
	H/

r~
?J@
o1
q
q
q
q3
?
?
q
	?

?
oG
C2
EEEEG
GEGG

C4
GC
EEEEGGEGG

C5GCEEEEGGEGG

C6GCEEEEGGEGG

C8HrHHHH

~
?J@
o7
q
q$
q
q

qP
	?

@
o:H
r*
z

9
	H

r~
?K@
o;
q
q
q
q


P
	?

?
H
r<
HHHr~
?K@
o
q
q
q
q

q
	q

q
G
CEEEEEGGC~
?L@
o=
q
q
q
qA

qC
	?

?
oEG
C>EEE
E@

ED
	GG

CFG
C?EEE
EB


	GG

CGGCEEEE

	GG

CHGCEEEEEGG

CIHrHH

C~
GL@
CZ
E
E
E
E_

E\
	G


oaG
C[EEE
E`

E]
	G

GCEEEE
E^	Gr~
?M@
oJ
q
q
q
qL

qP
	?

?
G
CNEEE
EK

Q	GGCDlLVlN8dD...nL6nnD..n8wAwAwAwAwAwAwAwAwA	wA
wAwAwA
wAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAwAG
COEEE
EM

ER	GGC~
?M@
oS
q
q
q

%
q
	?\

?
G
CTE
EUE
2

EZ	GGGCE
EE
E
	GS

GGCE
EVE
E[	GGGCE
EWEEGGGCE
EXEEGGGCE
EYEEGG~
?N@
oa
q
q
q
q_

qb
	?

?
og	G
	CY	EEE
	E]
	
	E
		GG

	Ch
GCEEE

E^



Ec

	GG


CiGCEEE
E`

Ed
	GG

jGCEEEEB
Ee	GBC
Hr

f
	Hr~
?N@
ok
q
q

q

q
	?

?
H
rb
HHr~
GO@
Cd
E
E$
Fg
Ek
G
W
DP
	G

W
CnG
Ce
EE
Fj

G
El
	G

CoG
Cf
EE
FhEG
Em
	G

GCEE
FiEHEGr~
?O@
ol
q
q$
qn
q
??
q
	?

?
CoG
CmEEEEGGEGG

CpHrHHHH

~
?P@
oq
q
q
q
r
?
?s
qt
	


~
?@P@
op
q
q
q
E
?
?
qr
	Gx

B
C~G
CEEE
Eq
GG
Es
	Gy

B
CGCEEEEGG
Et
	Gz

B|
CGCEEEEGG
Eu
	G{

B}
CGCEEEEGG
Ev
	GB

GCEEEEGG
Ew	GBCGCEEEEGG
	GBCHrEEEEHH
 	GBCDlbtdN888nZZ88Lzn8B.|RRD88 wA!wA"wA#wA$wA%wA&wA'wA(wA)wA*wA+wA,wA-wA.wA/wA0wA1wA2wA3wA4wA5wA6wA7wA8wA9wA:wA;wA<wA=wA>wA?wA~
 ?P@
 
 
 q
 q
 ?
 
 
 	?|
 
?
 o!G
!C!FEE
!E!
!
!
!	GG

!C"GCFEE
"G""GG

"C#GCFEE
#G#GG

#C$GCFEE
$E$GG

$C%HrHH

%~
&?P@
&ou
&q
&E
&E
&Ev
&&
&P
&	G&
G
&Cx'G
'Cc'EEE
'Ew'DGG

'Cy(GCEEE
((DGG

(Cz)GCEEEEDGG

)C{*GCEEEEDGG

*C|+GCEEEEDGG

+C},HrHH

,~~
-GQ@
-C
-E
-E
-E
-E
--
-EP
-	G-
B
-.G
.C.EEEEEGB

.C/GCEEEEBEGB

/C0HrH

0~
1?@Q@
1o
1q
1q
1q
1q
11
1qZ
1	?1

12GCEEE
2E2EGC3Hr
33Hr~
4?Q@
4o
4q
4q
4q
4q
4?
4?
4q
4	?
4
?
45H
5r5EHHHHr~
6?Q@
6o
6q
6q
6
6q
6
6?
6q
6	?&
6
?
6o7G
7C7EEF
77GEGG

78G
8C8EEF
8E8GEGGC~
9?R@
9o
9q
9q
9q
9q
9?
9?
9qP
9	?9
?
9o:GCE
:E
:E
:E:GGEGG

:C;GCEE
;E
;;GGEGG

;C<GCEE
<E<EGGEGG

<=GCEE
=E=EGGEGGC>GCEE
>E>EGGEGGC?Hr
??HHHHrD*
lnDDD.XD....B..886XL\PD88@wAAwABwACwADwAEwAFwAGwAHwAIwAJwAKwALwAMwANwAOwAPwAQwARwASwATwAUwAVwAWwAXwAYwAZwA[wA\wA]wA^wA_wA~
@G@R@
@A
@E
@E$
@E
@E
@@
@E
@	G
@

@AG
AA
AEE
AEAEEGC~
B?R@
Bo
Bq
Bq
Bq
Bq
BB
BqP
B	?B

BoCGCEEE
CECEG

C~
D?R@
Do
Dq
D$
Dq
Dq
DD
DqP
D	?
D

DoEG
ECEE
EF
EEEEEG

ECFGCE
FF
FEFEEG

FGGCEF
GEGEEGCHGCEF
HEHEEGCIHr
IIHr~
J?S@
Jo
Jq
Jq
Jq
J
JJ
Jq
J	?
J
?
JKH
KrKHHr~
LG@S@
LC
Lq
Lq
Lq
L
Lq
Lq
LD
L	G
L
Gp
LCMG
MCMEEE
MMGDGGCNGCEEE
NNGDGGCOGCEEE
OOGDGGCPGCEEE
PPHDGGC~
Q?S@
Qo
Qq
Qq
Qq
QqQ?
Q?
Qq
Q	?
Q
?
QRG
RCREEE
RERG
RGREGGCSGCEEEEG
SGSEGGCTGCEEEEG
TGTEGGCUGCEEEEG
UGUEGGCVHrH
VHVHHC~
WGS@
WC
Wq
WE$
WE
WE
W?
WL
WqP
W	?
W
L
WoXG
XCXEEE
XE
XG
XE
X	G

XCYGCEEE
YE
YG
YE
Y	G

YCZGCEEEEGEG

ZC[GCEEEEGEG

[C\GCEEEEHEG

\r~
]?T@
]o
]q
]q
]q
]q
]]
]qP
]	?]

]o^HrH

^~
_G@T@
_C
_q
_q
_q
_Ez
__
_q
_	_

_CDlLDbP8886L888`8888nZ....`wAawAbwAcwAdwAewAfwAgwAhwAiwAjwAkwAlwAmwAnwAowApwAqwArwAswAtwAuwAvwAwwAxwAywAzwA{wA|wA}wA~wAwA
`GC
`E`EEE
`E
`	

`CaGCEEEEE

a~
b?T@
bo
bq
bq
bq
bq
bb
bqP
b	b

bocG
cCcEEEEE
c	c

cCdG
dCxdEEEEE

dCeGCEEEEE

eCfGCEEEEE

fCgGCEEEEE

gChGCEEEEE

hCiGCEEEEE

iCjGCEEEEE

jCkHr

k~ll
mm
nn
oo
pp
qq
rr
ss
tt
uu
vv
ww
xx
yy
zz
{{
||
}}
~~

DzlZ.VB.......&&&&&&&&&&&&&&&&&&&wAwAwAwAwAwAwswswswswswswswswswswswswswswswswswswswswswswswswsws





tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
D@l&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&wswswswswswswswswswswswswswswswswswswswswswswswswswswswswswswswstuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
D@l&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&wswswswswswswswswswswswswswswswswstuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
tuuuuttutt
&@&&&&&&&&&&&&&&&&>Y@`urgggp]]^^]]	
^^	
nn	
__	
__~~}}  77	
			
\\[[88GGttwwxx||uuvvccHH	
	


			
	
&&	
''	
((	
1122bb	
cc	
DDEEJJKK]]bb&&''@@BBCC--..ggD
	T8
?}
dMbP?_*+%&M&d2?'M&d2?(~?)~?MESamsung ML-1860 Seriesg߁	4dXA4PRIV	x-ArialUntitled0:0:0:0:0dX222222222pichatA4dddddd			44@@44#"	dX
BP(?
BP(?&\(U}`


I
J
tJ

J
IJ
IJ

W	
W




3
KKKKKKKKK	LLLMM
	N
M	KMM
		N	
MMK
KKKKKKK	KKKKKKK	KKKKKKK	004.>@KJggD
	T8n12
dMbP?_*+%J&M&d2?'M&d2?(M&d2?)M&d2?MESamsung ML-1860 Seriesg߁	4dXA4PRIV	x-ArialUntitled0:0:0:0:0dX222222222pichatA4dddddd			44@@44#"	dX
BP(?
BP(?&\(U}	>}@>}
	>

@
J@
P
P
P
P
P
IP
 QQQQQQQQQQQQQ
P
P
P
P
P
PH0$>@QR
ggD
	T8SW
dMbP?_*+%J&M&d2?'\.?(\.?)\.?MESamsung ML-1860 Seriesg߁	4dXA4PRIV	x-ArialUntitled0:0:0:0:0dX222222222pichatA4dddddd			44@@44#"	dX
BP(?
BP(?&\(U}	>}@>}
	>

I
P
P
P
P
YP
I
P	
P

P
P
P

P
P
PPPPPPPPPP
ZRRRRRRRRRRRST
UUUUUUUUUUUV
T	UUUUUUUUUUUV

UVW
XXXXXXXXXXXY
O
OO
P
	P

P


P
P
P
P

P
P
P
P
P
P408008>@


ggD
	T8	xy
dMbP?_*+%&M&d2?'M&d2?(M&d2?)M&d2?MESamsung ML-1860 Seriesg߁	4dXA4PRIV	x-ArialUntitled0:0:0:0:0dX222222222pichatA4dddddd			44@@44#"	dX
BP(?
BP(?&\(U}	P								
[[
P
P
P
P
d>@PR


ggD
	T8 ǡ
dMbP?_*+%&jZ?'jZ?(~?)~?MESamsung ML-1860 Seriesg߁	4dXA4PRIV	x-ArialUntitled0:0:0:0:0dX222222222pichatA4dddddd			44@@44#"	dX
BP(?
BP(?&\(U}`\}@[}	\}\}@
\}@!\} \}	[ ]]PPPPPP	P
PPP
Phhhh

^ 
^!
^"
^#a
b'c____
`$
`%
`&~
f?
d(e98?
f)
f*
f+
file
f
f1
f9
f:jme
f-
f3
f;
f:~
j@
m,e
f.
f4
f<
f:jme
fy
f5
f=
f:jme
f/
f6
f>
f:	kne
	f0
	f7
	f?
	f:~

@

@
e

f

f2

f;

f:e
f-
fA
f=
f:~
f@
dB
e
fC
fD
f8
fE~

@

F
e

fG

fI

fK

f:e
fH
fJ
fL
f:gggggggggggggggggggggggg*h$Z<fHH^HHH^Hb^H>@gb			*



ggD
Oh+'0HP`p
jpichatPHARMicrosoft Excel@@*t?@X1v@՜.+,0HPX`hp
xj˹һӹ	˵͡ҧԧԸաҩմ
졪յ	

 !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~	

 !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQSTUVWXY[\]^_`aRoot Entry F@]AWorkbookSummaryInformation(RDocumentSummaryInformation8Z

Youez - 2016 - github.com/yon3zu
LinuXploit